Science

Mar 10, 2025, 09:12

Myeloma Paper of the Day, March 10th, suggested by Robert Orlowski

Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day: Myeloma cell intrinsic ANXA1 elevation and T cell dysfunction contribute to BCMA-negative relapse after CAR-T therapy, and ANXA1 inhibition may effectively diminish BCMA-negative myeloma.”

“Myeloma cell intrinsic ANXA1 elevation and T cell dysfunction contribute to BCMAnegative relapse after CAR-T therapy”

Authors: Shuangshuang Yang, Guixiang Wang, Jiahuan Chen, Wu Zhang, Jing Wu, Weiqing, Liu, Ling Bai, Peide Huang, Jianqing Mi, Jie Xu.

More posts featuring Robert Orlowski.

BCMA-negative myeloma cancer CAR-T therapy Guixiang Wang Jiahuan Chen Jianqing Mi Jie Xu Jing Wu Ling Bai LIU Myeloma Paper of the Day OncoDaily Oncology Peide Huang Robert Orlowski Shuangshuang Yang Weiqing Wu Zhang

Oncologist Near Me – Fedro Alessandro Peccatori: Leading Expert in Gynecological Oncology

MATTERHORN trial - FLOT plus durvalumab will become the new standard of care in the preoperative setting for gastroesophageal cancer

Daiichi Sankyo's and Astrazeneca's press release on ENHERTU®: Latest Updates from DESTINY-Gastric04 trial

13-year-old Cancer Survivor Sworn in as a Secret Service agent by President Trump - The White House

The European Parliament Intergroup on Cancer and Rare Diseases has been set in motion - ECO